Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Renal Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04933747
What this trial is testing

Study to Evaluate Safety and Tolerability of Iberdomide (CC-220) in Participants With Kidney Impairment Compared to Participants With Normal Kidney Function

Who this might be right for
Renal Insufficiency
Celgene 26
Early research (Phase 1)Study completedNCT01316055
What this trial is testing

Pharmacokinetics (PK) of Dalfampridine-ER 7.5 mg BID in Healthy Volunteers and Subjects With Mild or Moderate Renal Impairment

Who this might be right for
Renal Insufficiency
Acorda Therapeutics 42
Early research (Phase 1)Study completedNCT02144285
What this trial is testing

LY3113593 in Healthy Participants and Participants With Chronic Kidney Disease Treated With Hemodialysis

Who this might be right for
Kidney Failure, Chronic
Eli Lilly and Company 64
Large-scale testing (Phase 3)Study completedNCT03351166
What this trial is testing

Molidustat for Correction of Renal Anemia in Dialysis Subjects

Who this might be right for
AnemiaRenal Insufficiency, Chronic
Bayer 25
Large-scale testing (Phase 3)Study completedNCT03299244
What this trial is testing

Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT)

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease
Amgen 637
Large-scale testing (Phase 3)Study completedNCT03029208
What this trial is testing

Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID)

Who this might be right for
Anaemia
GlaxoSmithKline 312
Early research (Phase 1)Study completedNCT03482024
What this trial is testing

Tirzepatide (LY3298176) in Participants With Impaired Kidney Function

Who this might be right for
Renal InsufficiencyEnd Stage Renal Disease
Eli Lilly and Company 45
Early research (Phase 1)Study completedNCT01239459
What this trial is testing

Pharmacokinetic and Tolerability Study of 14 mg Single Dose of Teriflunomide in Subjects With Severe Renal Impairment

Who this might be right for
Renal Impairment
Sanofi 16
Post-approval studies (Phase 4)Study completedNCT00123461
What this trial is testing

Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary Hyperparathyroidism

Who this might be right for
Secondary HyperparathyroidismRenal FailureChronic Renal Insufficiency
Genzyme, a Sanofi Company 70
Early research (Phase 1)Study completedNCT01875523
What this trial is testing

PK of Serelaxin in Severe Renal Impairment and ESRD

Who this might be right for
Renal Failure, ChronicEnd-Stage Renal Disease
Novartis Pharmaceuticals 36
Large-scale testing (Phase 3)Ended earlyNCT00928811
What this trial is testing

Study to Evaluate the Safety of Chronic Administration of Simulect to Subjects Receiving a First Kidney Transplant

Who this might be right for
End Stage Renal Disease
Drexel University College of Medicine 5
Early research (Phase 1)Study completedNCT07070375
What this trial is testing

Pharmacokinetics and Safety of HRS-8427 in Healthy Volunteers and in Patients With Impaired Renal Function

Who this might be right for
Gram-negative Bacterial Infections
Jiangsu HengRui Medicine Co., Ltd. 33
Post-approval studies (Phase 4)Study completedNCT00803712
What this trial is testing

20070360 Incident Dialysis

Who this might be right for
Chronic Kidney DiseaseSecondary Hyperparathyroidism
Amgen 313
Early research (Phase 1)Study completedNCT04699032
What this trial is testing

Study of Pharmacokinetics and Safety of Apraglutide in Participants With Normal and Impaired Kidney Function.

Who this might be right for
Chronic Kidney Disease
VectivBio AG 16
Early research (Phase 1)Study completedNCT05489614
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Olpasiran in Participants With Normal Renal Function and Participants With Various Degrees of Renal Impairment

Who this might be right for
Renal Impairment
Amgen 33
Testing effectiveness (Phase 2)Ended earlyNCT00381602
What this trial is testing

A Phase II, Randomized, Cross-Over, Vehicle-Controlled, Double-Blind, Multicenter Study of the Safety, Pharmacodynamics, and Preliminary Efficacy of GHRP-1/AG in Subjects With ESRD on Hemodialysis

Who this might be right for
End Stage Renal Disease
QLT Inc. 3
Not applicableStudy completedNCT00696605
What this trial is testing

Assessment of Circulating Copeptin Levels in Healthy Subjects and Patients With Renal Insufficiency After Oral Water Load and Hypertonic Saline Infusion

Who this might be right for
HypoosmolalityHyperosmolalityRenal Failure
Hospital Centre Biel/Bienne 20
Early research (Phase 1)Study completedNCT01737866
What this trial is testing

Pharmacokinetics Study of AMG 423 in Healthy Subjects and Subjects With Various Degrees of Renal Insufficiency

Who this might be right for
Heart Failure
Cytokinetics 13
Early research (Phase 1)Study completedNCT04348175
What this trial is testing

Evaluate the Pharmacokinetics of Setmelanotide in Subjects With Varying Degrees of Renal Impairment

Who this might be right for
Renal Insufficiency
Rhythm Pharmaceuticals, Inc. 32
Early research (Phase 1)Study completedNCT00792857
What this trial is testing

Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT)

Who this might be right for
Chronic Kidney DiseaseSecondary HyperparathyroidismChronic Renal Insufficiency+1 more
OPKO IP Holdings II, Inc. 24
Next Page